Home › Researcher directory › Massimo Cristofanilli
Massimo Cristofanilli
Affiliation : NewYork–Presbyterian Hospital · Weill Cornell Medicine
- 14Publications (affiliation in the United States)
- 1477Total publications
- 58539Citations
- 112h-index
Research profile
Massimo Cristofanilli has 14 indexed publications (2010–2026). Their work appears mainly in “Cancer Research”, “npj Breast Cancer” and “Science Translational Medicine”. Their most cited article, “Phase II Study to Evaluate the Efficacy and Safety of Neoadjuvant Lapatinib Plus Paclitaxel in Patients With Inflammatory Breast Cancer” (2010), has been cited 70 times. 10 of these publications date from the last three years of activity. Their work is co-authored with at least 12 researchers, including institutions in Tunisia, Italy, France.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsResearch areas
- Breast Cancer Treatment Studies
- Cancer Cells and Metastasis
- Cancer Genomics and Diagnostics
- Breast Lesions and Carcinomas
- Advanced Breast Cancer Therapies
Publications (14)
- Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value
- Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025
- Inflammatory breast cancer: Improving research and care through the integration of preclinical evidence and technological advances
- Multi-analyte liquid biopsy characterization of metastatic inflammatory breast cancer: comparison with non-inflammatory breast cancer
- Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis
- 84P Tumor microenvironment modulation in inflammatory breast cancer
- Inflammatory breast cancer: Epidemiologic data and therapeutic results
- Abstract PO3-06-05: Association of tumor-derived extracellular vesicles with circulating tumor DNA alterations in metastatic breast cancer patients: exploring differences in inflammatory breast cancer
- Abstract PO3-14-12: SIRT3 as a new potential predictive biomarker for response to CDK4/6 inhibition in ER+/HER2- metastatic breast cancer patients
- Abstract PO3-14-11: Association between BRCA alterations detected by circulating tumor DNA and germline mutations in breast cancer patients: a retrospective mono-institutional analysis
- Real-time assessment of HER2 status in circulating tumor cells of breast cancer patients: Methods of detection and clinical implications
- Abstract P6-10-15: Targeting MARCKS in inflammatory breast cancer increased paclitaxel sensitivity
- MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer
- Phase II Study to Evaluate the Efficacy and Safety of Neoadjuvant Lapatinib Plus Paclitaxel in Patients With Inflammatory Breast Cancer
Publication venues
- Cancer Research × 4
- npj Breast Cancer × 2
- Science Translational Medicine × 1
- Cancer × 1
- Critical Reviews in Oncology/Hematology × 1
- ESMO Open × 1
Publications per year
- 20264
- 20252
- 20244
- 20232
- 20221
- 20101
Collaborations
Partner institutions : Northwestern University · The University of Texas MD Anderson Cancer Center · Institut Salah-Azaïz · Tunis El Manar University · Duke Medical Center
Co-authors’ countries : Tunisia · Italy · France
Co-authors
- Carolina Reduzzi
- Eleonora Nicolò
- Nadia Bayou
- Maroua Manai
- Mara Serena Serafini
- Elisabetta Molteni
- Letizia Pontolillo
- Huiping Liu
- William John Gradishar
- Jeannine Donahue
- Paolo D’Amico
- Andrew A. Davis
Bibliographic data from OpenAlex (open database).
Why choose Dzcademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.